Article Versions Notes

Koike R, Sawahata M, Nakamura Y, Nomura Y, Katsube O, Hagiwara K, Niho S, Masuda N, Tanaka T, Sugiyama K. Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination. Vaccines. 2022; 10(3):451. https://doi.org/10.3390/vaccines10030451

Koike, Ryousuke, Michiru Sawahata, Yosikazu Nakamura, Yushi Nomura, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, and Kumiya Sugiyama. 2022. "Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination" Vaccines 10, no. 3: 451. https://doi.org/10.3390/vaccines10030451

Koike, R., Sawahata, M., Nakamura, Y., Nomura, Y., Katsube, O., Hagiwara, K., Niho, S., Masuda, N., Tanaka, T., & Sugiyama, K. (2022). Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination. Vaccines, 10(3), 451. https://doi.org/10.3390/vaccines10030451